The role of B7 family molecules in hematologic malignancy

165Citations
Citations of this article
189Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The B7 family consists of structurally related, cell-surface proteins that regulate immune responses by delivering costimulatory or coinhibitory signals through their ligands. Eight family members have been identified to date including CD80 (B7-1), CD86 (B7-2), CD274 (programmed cell death-1 ligand [PD-L1]), CD273 (programmed cell death-2 ligand [PD-L2]), CD275 (inducible costimulator ligand [ICOS-L]), CD276 (B7-H3), B7-H4, and B7-H6. B7 ligands are expressed on both lymphoid and nonlymphoid tissues. The importance of the B7 family in regulating immune responses is clear from their demonstrated role in the development of immunodeficiency and autoimmune diseases. Manipulation of the signals delivered by B7 ligands shows great potential in the treatment of cancers including leukemias and lymphomas and in regulating allogeneic T-cell responses after stem cell transplantation. © 2013 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Greaves, P., & Gribben, J. G. (2013, January 31). The role of B7 family molecules in hematologic malignancy. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-10-385591

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free